EDIT
Price
$1.45
Change
+$0.06 (+4.32%)
Updated
May 9 closing price
Capitalization
121.38M
One day until earnings call
NRIX
Price
$9.50
Change
-$0.14 (-1.45%)
Updated
May 9 closing price
Capitalization
724.24M
60 days until earnings call
Ad is loading...

EDIT vs NRIX

Header iconEDIT vs NRIX Comparison
Open Charts EDIT vs NRIXBanner chart's image
Editas Medicine
Price$1.45
Change+$0.06 (+4.32%)
Volume$2.65M
Capitalization121.38M
Nurix Therapeutics
Price$9.50
Change-$0.14 (-1.45%)
Volume$575.75K
Capitalization724.24M
EDIT vs NRIX Comparison Chart
Loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EDIT vs. NRIX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EDIT is a Hold and NRIX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (EDIT: $1.45 vs. NRIX: $9.50)
Brand notoriety: EDIT and NRIX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EDIT: 122% vs. NRIX: 55%
Market capitalization -- EDIT: $121.38M vs. NRIX: $724.24M
EDIT [@Biotechnology] is valued at $121.38M. NRIX’s [@Biotechnology] market capitalization is $724.24M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EDIT’s FA Score shows that 1 FA rating(s) are green whileNRIX’s FA Score has 1 green FA rating(s).

  • EDIT’s FA Score: 1 green, 4 red.
  • NRIX’s FA Score: 1 green, 4 red.
According to our system of comparison, both EDIT and NRIX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EDIT’s TA Score shows that 5 TA indicator(s) are bullish while NRIX’s TA Score has 4 bullish TA indicator(s).

  • EDIT’s TA Score: 5 bullish, 5 bearish.
  • NRIX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both EDIT and NRIX are a good buy in the short-term.

Price Growth

EDIT (@Biotechnology) experienced а -11.59% price change this week, while NRIX (@Biotechnology) price change was -15.71% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

EDIT is expected to report earnings on Jul 30, 2025.

NRIX is expected to report earnings on Jul 10, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NRIX($724M) has a higher market cap than EDIT($121M). EDIT YTD gains are higher at: 14.173 vs. NRIX (-49.575). NRIX has higher annual earnings (EBITDA): -214M vs. EDIT (-233.11M). NRIX has more cash in the bank: 550M vs. EDIT (270M). NRIX has less debt than EDIT: NRIX (26.6M) vs EDIT (35M). NRIX has higher revenues than EDIT: NRIX (56.4M) vs EDIT (32.3M).
EDITNRIXEDIT / NRIX
Capitalization121M724M17%
EBITDA-233.11M-214M109%
Gain YTD14.173-49.575-29%
P/E RatioN/AN/A-
Revenue32.3M56.4M57%
Total Cash270M550M49%
Total Debt35M26.6M132%
FUNDAMENTALS RATINGS
EDIT: Fundamental Ratings
EDIT
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
53
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EDITNRIX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 18 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
EDIT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIADX52.980.19
+0.36%
Fidelity Advisor International Discv I
BCIFX205.300.61
+0.30%
Blue Chip Investor
PGINX23.340.06
+0.26%
Impax Global Environmental Markets Instl
FSKGX18.15-0.01
-0.06%
Fidelity Growth Strategies K6
NMUCX9.36-0.01
-0.11%
Neuberger Berman Multi-Cap Opp C